Elicio Therapeutics Inc

The current institutional shareholding score of Elicio Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 15.12%, representing a quarter-over-quarter increase of 37.43%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.66% of shares outstanding, with 3.56% increase in holdings.